Home⇛The PCMC Journal⇛vol. 15 no. 1 (2019)

Effects of probiotic prophylaxis on the incidence of ventilator – associated pneumonia among critically ill pediatric patients: a meta-analysis

Carolyn Grace C. Tongson | Maria Eva I. Jopson

Discipline: medicine by specialism

 

Abstract:

BACKGROUND: Among critically ill pediatric patients, a common complication experienced is nosocomial pneumonia. One field that garnered special interests as an alternative and promising way of preventing infection is the utilization of Probiotics. But whether it can prevent occurrence of ventilatorassociated pneumonia (VAP) among critically ill pediatric patients remains unclear OBJECTIVES: To determine whether probiotic supplementation will prevent the incidence of ventilatorassociated pneumonia among critically ill pediatric patients. METHODS: Literature search was conducted in PubMed, MEDLINE, EMBASE, CINAHL, SciHub, Herdin, Google Scholar, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews to identify all relevant randomized controlled trials (RCTs) published between 1980 and 2016. The reviewers extracted data and reviewed the quality of the studies independently. RESULTS: Three randomized controlled studies with a total of 327 pediatric patients admitted at the PICU were analyzed. Pooled analysis showed a statistically significant reduction in nosocomial pneumonia rates (odd ratio [OR] = 0.31, 95% CI 0.18 to 0.55, P< 0.0001, I 2 = 53%) and statistically significant difference was found regarding overall mortality (OR =0.51 , 95% CI 0.30 to 0.88, P = 0.01, I 2 = 0%) due to probiotics. However, no statistically significant difference was found between groups regarding duration of stay in the PICU (Mean Difference [MD] in days = 2.93, 95% CI 1.84 to 4.01, P < 0.00001, I2 = 97% ), and duration of stay in the hospital (MD = 4.33 days, 95% CI 2.85 to 5.81, P < .00001, I 2 = 97%). CONCLUSION AND RECOMMENDATIONS: The use of probiotics was associated with statistically significant reduction in the incidence of VAP in critically ill children. However, larger and well-designed, multi-center, RCTs are needed to further establish the effects of probiotic in the pediatric population of critically ill children who are at risk of developing nosocomial infection.



References:

  1. McNabb B, Isakow W. Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med. 2008 May;14(3):168-75.
  2. Simon AG, Rogacion J. A randomized placebo-controlled trial on the use of probiotics in the prevention of nosocomial infection in pediatric patients with hematologic and oncologic diseases. PIDSP Journal. 2005;9(2). Available from: http://www.pidsphil.org/pdf/Journal_02050821/jo31_ja03.pdf
  3. Estes RJ, Meduri GU. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonisation and airway inoculation. Intensive Care Med. 1995;21:365-83.
  4. Oudhuis GJ, Bergmans DC, Dormans T, Zwaveling JH, Kessels A, Prins MH, et al. Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med. 2011;37:110-7.
  5. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis. 2002;46(Suppl 2):S87-91.
  6. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2-13.
  7. Coconnier M, Bernet M, Kerneis S, Chauviere G, Fourniat J, Servin A. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett. 1993;110:299-305.
  8. Agarwal K, Bhasin S, Faridi M, Mathur M, Gupta S. Lactobacillus casei in the control of acute diarrhea: a pilot study. Indian Pediatr. 2001;38:905-10.
  9. Honeycutt TC, Khashab ME, Wardrop RM, McNeal-Trice K, Honeycutt AL, Christy C, et al. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med. 2007;8(5):452-8.
  10. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001 Mar;138(3):361-5.
  11. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody-secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141-4.
  12. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al. Effect of long-term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ. 2001;322:1327-9.
  13. Minocha A. Probiotics for preventive health. Nutr Clin Pract. 2009 Apr;24(2):227-41.
  14. Oudhuis G, Bergmans D, Verbon A. Probiotics for prevention of nosocomial infections: efficacy and adverse effects. Curr Opin Crit Care. 2011;17:487-92.
  15. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis. 2002;46(Suppl 2):S87-91.
  16. Navoa-Ng JA, Berba R, Galapia YA, Rosenthal VD, Villanueva VD, Tolentino MC, et al. Device-associated infection rates in adult, pediatric, and neonatal intensive care units of hospitals in the Philippines: International Nosocomial Infection Control Consortium (INICC) findings. Am J Infect Control. 2011 Sep;39(7):548-54.
  17. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182:1058-64.
  18. Barraud D, Blard C, Hein F, Marçon O, Cravoisy A, Nace L, et al. Probiotics in the critically ill patient: a double-blind, randomized, placebo-controlled trial. Intensive Care Med. 2010;36:1540-7.
  19. Snydman DR. The safety of probiotics. Clin Infect Dis. 2008;46(Suppl 2):S104-11.
  20. Johns Hopkins Bloomberg School of Public Health. Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PLoS One. 2010;5(8):e12164.
  21. Katelaris P. Probiotics control of diarrheal disease. Asia Pac J Clin Nutr. 1996;5:39-43.
  22. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics. 2002 May;109(5):758-64.
  23. Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing clinical research: an epidemiologic approach. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. Appendix 6B, p.75.
  24. Banupriya B, Biswal N, Srinivasaraghavan R, Narayanan P, Mandal J. Probiotic prophylaxis to prevent ventilator-associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial. Intensive Care Med. 2015;41:677-85.
  25. El-Wakeel N, Wakeel A, El-Assmy M, El-Ghada B, Soliman W. Role of probiotics in prevention of hospital acquired pneumonia in Egyptian children admitted to Pediatric Intensive Care Unit of Mansoura University Children’s Hospital. Afr J Microbiol Res. 2016;10:1240-7.
  26. Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2009;65:561-70.
  27. Watkinson PJ, Barber VS, Dark P, Young JD. The use of pre-, pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr. 2007;26:82-92.
  28. Oudhuis GJ, Bergmans DC, Dormans T, Zwaveling JH, Kessels A, Prins MH, et al. Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med. 2011;37:110-7.
  29. Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomized controlled open pilot study. Crit Care. 2008;12:R136.
  30. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:954-62.
  31. Sun S, Yang K, He X, Tian J, Ma B, Jiang L. Probiotics in patients with severe acute pancreatitis: a meta-analysis. Langenbecks Arch Surg. 2009;394:171-7.

Tools


Copyright © 2025  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic